Articles

Whether someone is struggling with acute or chronic pain, cannabis can be a powerful tool as an alternative or adjunct treatment.

How Can Cannabis Be a Path from Pain toward Restored Function?

Madeline Colli is the Associate Editor for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

A Brazilian university has detected cannabidiol (CBD) in a native plant called Trema micrantha blume.

Brazilian Plant Found to Contain CBD

ProjectCBD provided a detailed summary of some of the recent research on cannabis for treating irritable bowel disease (IBD).

The Potential of CBD in Treating IBD: Recent Studies Shed Light on Symptom Relief and Patient Experiences

Our sister publication, Oncology Nursing News recently published an interview with Karen Hande, PhD, DNP, ANP-BC, CNE, FAANP, ANEF, where she discusses increased patient interest in cannabinoids and how oncology nurses can steer pain management conversations to keep patients informed.

Interest in Cannabinoids Continues to Grow Among Patients With Cancer

The Nova Scotia House of Assembly recently heard a petition to cover the cost of CBD-based medications for certain conditions.

Petition Calls on Nova Scotia Government to Cover Cost of Cannabidiol-Based Medications for Children with Life-Threatening Diseases

One recently published study suggests that a cannabis sublingual spray may be beneficial in the treatment of type 2 diabetes.

The Effects of a Sublingual Cannabis Spray on Patients with Type 2 Diabetes

When you think of cannabis, you probably don’t think of horses or the potential medicinal benefit to animals. However, the cannabinoids found in cannabis have been shown to provide similar benefits in animals that are noted with human patients. In this interview, Emma Davis, founder of Mikko’s Choice, delves into how some cannabinoids—such as tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinolic acid (THCA)—have provided medicinal benefits to horses. Davis also discusses her mustang, Mikko, who inspired her to launch her own cannabis and hemp product brand.

Breaking the Reins: How One Mustang Found a Second Chance with CBD

Recently, the University of Oxford began an international study to examine the potential therapeutic benefits of cannabidiol (CBD) in treating psychosis or psychotic symptoms.

Cannabidiol for Potentially Treating Psychosis: International Study Launched by University of Oxford

Cannabidiol (CBD) was recently studied in Mexico as a treatment for traumatic brain injury and Parkinson’s Disease.

Recent Studies from Medical Marijuana Inc. Test Cannabidiol for Treatment of Two Conditions

Meg is the Group Editorial Director for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.